Neutrolis, Inc. is a biotechnology company developing therapeutics that target neutrophils, the most abundant immune cell in our body.
Neutrolis’ lead program targets Neutrophil Extracellular Traps (NETs). NETs are a fundamental arm of the innate immune system and play an important role in chronic and acute diseases.
Based in Cambridge, MA, Neutrolis was founded by two of the earliest and most cited leaders in the NETs field and supported by seasoned business leaders.
Company Details
- Employees
- 14
- Founded
- -
- Address
- 1 Broadway,
- Industry
- Biotechnology
- Website
- neutrolis.com
- HQ
- Cambridge, Massachusetts
Neutrolis Inc Questions
Neutrolis Inc's website is neutrolis.com
Neutrolis Inc's LinkedIn profile is https://www.linkedin.com/company/neutrolis
Neutrolis Inc has
14 employees.
View email and phone details for 14
employees at Neutrolis Inc.
Neutrolis Inc's industry is
Biotechnology
Neutrolis Inc's top competitors are
Morningside,
Artus Therapeutics,
Latchbio,
Moderna,
Apertura Gene Therapy,
Manus,
Calbiotech, Inc,
Kdt Ventures,
Targetrna Inc.,
Siro Diagnostics.
Neutrolis Inc's categories are Biotechnology
Neutrolis Inc's founding year is 2017
